Integra Lifesciences Holdings (IART) Inventory (2009 - 2026)

Integra Lifesciences Holdings has disclosed Inventory across 18 years of filings, most recently posting $492.0 million for Q2 2026.

• In Q2 2026, Inventory rose 5.78% year-over-year to $492.0 million; the TTM figure through Jun 2026 stood at $492.0 million (up 5.78% YoY), while the FY2025 annual figure was $492.7 million, up 14.83% from the prior year.
• Inventory came in at $492.0 million for Q2 2026 at Integra Lifesciences Holdings, down from $495.0 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $495.0 million in Q1 2026 to a low of $311.1 million in Q3 2022.
• Average Inventory over 5 years is $406.4 million, with a median of $412.6 million recorded in 2024.
• Year-over-year, Inventory fell 4.92% in 2022 and increased 20.03% in 2023.
• Over 5 years, Inventory stood at $324.6 million in 2022, then advanced by 20.03% to $389.6 million in 2023, then climbed by 10.13% to $429.1 million in 2024, then grew by 14.83% to $492.7 million in 2025, then declined by 0.15% to $492.0 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $492.0 million in Q2 2026, $495.0 million in Q1 2026, and $492.7 million in Q4 2025.